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A reporter gene under the control of a T-cell antigen receptor response element was activated m Jurkat cells by antigen receptor triggering or by 
a combination of phorbol myristate acetate, which activates protein kinase C, and a calcium ionophore. Both these signals were necessary for 
expression of the reporter gene. When co-transfected wrth a construct capable of overexpressing the tyrosme kinase p59fyn, the reporter gene was 
activated by PMA alone. Thus p59fyn could replace the calcium ionophore but not activation of protein kmase C. The activation by p59fyn plus 
PMA was blocked by EGTA and by the immunosuppressant drug cyclosporin A. 
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1. INTRODUCTION 
T-cell recognition of specific antigen is achieved by a 
membrane-associated polymorphic a/? heterodimer 
which interacts with peptide antigen complexed with 
major histocompatibility proteins expressed on the sur- 
face of antigen presenting cells. The CX/? heterodimeric 
recognition molecules have very short cytoplasmic do- 
mains and are unlikely to be capable of transducing 
regulatory signals alone. At least five other transmem- 
brane polypeptide chains are associated with the a/l 
heterodimer to form the T-cell antigen receptor complex 
(TCR). None of the transmembrane polypeptides has 
any known enzymatic activity (reviewed in [1,2]). 
viewed in [4]). Full T-cell activation, however, requires 
a sustained increase in intracellular free calcium from 
extracellular sources [5]. Both these signals, PKC acti- 
vation and calcium mobilisation, are essential and suffi- 
cient to activate the antigen response elements of the 
interleukin-2 promoter which in combination with ac- 
cessory signals results in IL-2 expression. Expression of 
IL-2 and IL-2 receptors leads to initiation of an auto- 
crine growth loop and is a key event in T-cell activation 
(reviewed in [6]). 
Early events after TCR engagement include protein 
phosphorylation on tyrosine residues followed by acti- 
vation of protein kinase C (PKC) and increased intra- 
cellular free calcium (reviewed in [2]). At least part of 
the PKC activation and calcium mobilisation are be- 
lieved to be mediated by phospholipase Cy which is 
activated by tyrosine phosphorylation [3]. Phospholip- 
ase Cy metabolism of membrane phospholipids results 
in the release of diacylglycerol, a physiological activator 
of PKC, and inositol triphosphate which induces a tran- 
sient release of calcium from intracellular stores (re- 
The protein tyrosine kinase p59fyn [7,8] is found 
physically associated with the intracellular domain of 
the TCR complex and is therefore likely to be involved 
in TCR signal transduction [9]. Several lines of evidence 
support this view. Most convincing is that disruption of 
both homologues of the p59fyn gene in mice results in 
severe impairment of TCR signaling in thymocytes and 
to a lesser extent in splenocytes. In particular, thy- 
mocytes from p59fyn deficient mice fail to mobilise cal- 
cium on TCR engagement [lO,ll]. In addition, intro- 
duction of a constitutively active form of p59fyn into 
T-cells results in an enhanced proliferative response to 
TCR triggering [ 121 and enhanced calcium mobilisation 
u31. 
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In the work reported here we have studied the role of 
p59fyn in IL-2 promoter activation in a Jurkat cell 
model of T-cell activation. We show that overexpres- 
sion of p59fyn contributes to activation of a reporter 
gene under the control of a synthetic promoter contain- 
ing a multimer of the antigen receptor response element 
[14] which is recognised by the NF-AT transcription 
factor. In addition we show that overexpression can, at 
least in part, replace the requirement for agents which 
mobilise calcium but not agents which activate PKC. 
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2. MATERIALS AND METHODS 
2.1. Cell culture. transfectmns and CAT (Issays 
Transfections, activations. protein determmations and CAT assays 
were carried out as described [15,16]. Each sample resulted from trans- 
fection of 1 x lo6 cells with 0.5 pg NF-AT/CAT and 1 pg of either 
fyn/CMV or vector. To minimize the variability among samples, acti- 
vations were done on aliquots of a smgle pool of transfected cells. 
When p59fyn transfected cells were compared with control cells, the 
transfection mix. including the indicator plasmids, was prepared, then 
divided into aliquots to which were added either the p59fyn plasmid 
or the same vector lacking fyn sequences. Cells were activated 30 h 
after transfection. EGTA or Cyclosporin A (Sandoz) was added 30 
min before activation. 0KT3 (ATCC) hybridoma supernatant was 
enriched in the IgG fraction by affinity purification on protein G- 
Sepharose (MabTrap. Pharmacia). 
2.2. Quantitatron of CAT ussays 
Autoradiograms were scanned using an LKB Ultrascan XL en- 
hanced laser densitometer and evaluated using GSXL software. Each 
experiment was carried out 33.5 times. The results of representative 
experiments are shown. 
2.3. Phnids 
NF-AT/CAT (a gift of G.R. Crabtree) contains a trimer of the 
NF-AT binding site of the IL-2 promoter upstream of the CAT gene 
[17]. Human p59fyn cDNA (a generous gift of M. Toyoshima) was 
subcloned into the polylinker of the CMV expression vector pcDNAI 
(Invitrogen). 
-CE-CE 
3. RESULTS AND DISCUSSION 
The T-cell specific transcription factor, NF-AT, is 
activated by TCR engagement or by a combination of 
PKC activation and sustained calcium mobilisation. 
The PKC and calcium mediated signals operate inde- 
pendently on two different subunits of the NF-AT fac- 
tor. PKC activation results in the induction of expres- 
sion of the gene coding for one subunit and calcium 
mobilisation results in translocation of a second subunit 
from the cytoplasm to the nucleus where the active tran- 
scription factor is formed. The activation of both these 
subunits is essential for NF-AT activity [18]. 
The reporter plasmid NF-AT/CAT contains the bac- 
terial gene for chloramphenicol acetyl transferase 
(CAT) under the control of a synthetic promoter con- 
sisting of three copies of the NF-AT binding site up- 
stream of a minimal y-fibrinogen promoter [17]. When 
introduced into cells of the human lymphoma line, Jur- 
kat, this promoter can be activated by monoclonal anti- 
bodies against the TCR/CD3 complex or by nonspecific 
agonists of the TCR such as phytohemagglutinin. These 
signals can be mimicked by a combination of phorbol 
myristate acetate (PMA), which activates PKC, and a 
calcium ionophore (A23 187) [ 17.191. 
Fig. 1 shows the results of CAT assays of extracts of 
Jurkat cells transfected with the NF-AT/CAT reporter 
plasmid and treated with various stimuli. In the absence 
of stimulus, no CAT activity was detected. Treatment 
with PHA or a combination of PMA and A231 87 re- 
sulted in significant CAT activity. PMA or A23187 
alone had no effect. A combination of anti-CD3 anti- 
0 PM A PH - PM/A-- PM/3 - 
Fig. 1. Activation of NF-AT m Jurkat cells, CAT assays of protein 
extracts of Jurkat cells transfected with NF-AT/CAT and activated as 
shown below each lane m the presence or in the absence of CsA (200 
ng/ml) or EGTA (2 mM). 0. non activated; PM, PMA 10 @ml; PH, 
PHA 2 pug/ml; A, A23187 100 &ml; 3. 0KT3 Mab. 1 pg/ml. 
bodies and PMA gave a lower but still significant acti- 
vation. As has been previously reported [17,20], activa- 
tion of the NF-AT/CAT construct was completely 
blocked by removal of calcium ions from the culture 
medium by EGTA or by the immunosuppressant drug 
cyclosporin A (CsA). which blocks calcium-dependent 
pathways of signal transduction. 
Fig. 2 shows the results of CAT assays of Jurkat cells 
co-transfected with the NF-AT/CAT reporter plasmid 
and a plasmid containing a cDNA encoding p59fyn 
under the control of a strong constitutively active pro- 
moter. In the absence of stimulation or in cells treated 
with A23 187 no CAT activity was detectable. However, 
after treatment with PMA, significant CAT activity was 
observed. This activity was approximately 40% of the 
0,s 1 
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Fig 2. p59fyn contributes to antigen receptor signaling. Relative ab- 
sorbance values of acetylated [‘YZ]chloramphenicol in autoradiograms 
of CAT assays of Jurkat cells co-transfected with NF-AT/CAT and 
either a control plasmid (left) or an expression plasmid encoding 
p59fyn (right) and activated as shown below each lane. 0. not acti- 
vated; PMA. PMA 10 rig/ml; A, A23187. 100 ng/ml. The results are 
representative of several Independent experiments. 
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Fig. 3. NF-AT activation by p56fyn is calcium dependent and cy- 
closporin A sensitive. Relative absorbance values of acetylated 
[‘4C]chloramphenicol in autoradiograms of CAT assays of Jurkat cells 
co-transfected with NF-AT/CAT and the expression plasmid encod- 
ing p56fyn and activated as shown in the absence or in the presence 
of 2 mM EGTA or 200 ng/ml CsA. PMA, PMA 10 ng/ml. 
CAT activity obtained after treatment with PMA and 
A23187 which fully induce the NF-AT synthetic pro- 
moter but was similar to that obtained by anti-CD3 
antibodies plus PMA. Thus overexpression of p59fyn, 
at least partially, replaced the requirement for a calcium 
mobilising agent but not of PKC activation. 
This result supports the hypothesis that p59fyn con- 
tributes to TCR signal transduction and that its func- 
tion is mediated, at least in part, by the transcription 
factor NF-AT. Furthermore, the fact that it synergises 
with PMA and not A23187 indicates that it is involved 
in the calcium-mediated pathway. The signal obtained 
with PMA treatment of p59fyn transfected cells was 
never more than 40% of the signal obtained by treat- 
ment with PMA plus A23187. This may suggest that 
p59fyn cannot completely replace the calcium-depend- 
ent signal, however in transient cotransfection experi- 
ments it is unlikely that all cells which took up the 
reporter gene also took up the p59fyn expression con- 
struct. 
To further investigate the role of p59fyn in calcium 
signaling, Jurkat cells transfected with the NF-AT re- 
porter plasmid and the fyn expressing plasmid were 
treated with PMA in absence or presence of EGTA to 
remove calcium from the medium. The results are 
shown in Fig. 3. EGTA completely blocked the syner- 
gism between p59fyn and PMA. EGTA at this concen- 
tration has no effect on the activation of calcium inde- 
pendent promoters in these cells [16]. Since p59fyn acti- 
vation of NF-AT requires the presence of calcium ions 
in the cell culture medium, it must play a role upstream 
of the calcium signal. This is in agreement with the fact 
that thymocytes from p59fyn depleted transgenic mice 
do not mobilize calcium in response to TCR engage- 
ment [lO,ll]. 
Similar results were obtained using the immunosup- 
pressant drug CsA which specifically blocks calcium- 
dependent signal transduction in T-cells [ 161. CsA inhib- 
its the calcium-dependent protease, calcineurin, which 
is believed to mediate the calcium-dependent activation 
of IL-2 expression [21]. In the presence of CsA, p59fyn/ 
PMA activation of NF-AT was completely abrogated 
(Fig. 3). 
We conclude that p59fyn mediates activation of IL-2 
expression by TCR and that it is involved in TCR mod- 
ulation of calcium influx from extracellular sources. We 
have recently shown that a constitutively active form of 
the CD4-associated kinase p561ck [22] has similar prop- 
erties [20] and in addition, overexpression of wild-type 
p561ck also results in calcium mediated activation of 
NF-AT (Baldari and Telford, unpublished). It is not 
clear however if p561ck and p59fyn are part of a single 
signaling pathway or if they function independently. 
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